Ahmed Sabet - Precipio Chief Officer
| PRPO Stock | USD 5.72 0.23 3.87% |
Insider
Ahmed Sabet is Chief Officer of Precipio
| Age | 38 |
| Address | 4 Science Park, New Haven, CT, United States, 06511 |
| Phone | 203 787 7888 |
| Web | https://www.precipiodx.com |
Ahmed Sabet Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ahmed Sabet against Precipio stock is an integral part of due diligence when investing in Precipio. Ahmed Sabet insider activity provides valuable insight into whether Precipio is net buyers or sellers over its current business cycle. Note, Precipio insiders must abide by specific rules, including filing SEC forms every time they buy or sell Precipio'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ahmed Sabet over six months ago Acquisition by Ahmed Sabet of 750 shares of Precipio at 0.5974 subject to Rule 16b-3 |
Precipio Management Efficiency
The company has return on total asset (ROA) of (0.1898) % which means that it has lost $0.1898 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2922) %, meaning that it created substantial loss on money invested by shareholders. Precipio's management efficiency ratios could be used to measure how well Precipio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -1.16. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, Precipio's Total Assets are very stable compared to the past year. As of the 28th of November 2024, Other Current Assets is likely to grow to about 653.3 K, while Non Current Assets Total are likely to drop about 11.8 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Simon Morriss | Genetic Technologies | 51 | |
| Ryan Siurek | Biodesix | 52 | |
| Annette Baumgartner | Psychemedics | N/A | |
| Stephen Hughes | Applied DNA Sciences | N/A | |
| RN RN | Castle Biosciences | 56 | |
| Steven Graves | Sera Prognostics | N/A | |
| John Abbott | Castle Biosciences | N/A | |
| Michael McGarrity | MDxHealth SA ADR | 61 | |
| Matt Stauffer | Biodesix | N/A | |
| Paul Marr | MDxHealth SA ADR | N/A | |
| Richard Coleman | Star Equity Holdings | 68 | |
| Ron Kalfus | MDxHealth SA ADR | 50 | |
| Matthew Molchan | Star Equity Holdings | 57 | |
| Sean MD | Sera Prognostics | N/A | |
| Dr III | Biodesix | 53 | |
| John Shearman | Applied DNA Sciences | N/A | |
| MeiLin Wan | Applied DNA Sciences | N/A | |
| Xavier MS | bioAffinity Technologies, | 54 | |
| Yusheng Han | Burning Rock Biotech | 45 | |
| MingChou Lee | Exagen Inc | N/A | |
| Shaokun Chuai | Burning Rock Biotech | 45 | |
Management Performance
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.19 |
Precipio Leadership Team
Elected by the shareholders, the Precipio's board of directors comprises two types of representatives: Precipio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precipio. The board's role is to monitor Precipio's management team and ensure that shareholders' interests are well served. Precipio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precipio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ahmed Sabet, Chief Officer | ||
| Miri ChikoRadomski, Chief Officer | ||
| Keith Meadors, VP Division | ||
| Matthew Gage, Interim Officer | ||
| Ilan Danieli, President CEO, Director | ||
| Ayman MD, Chief Officer |
Precipio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precipio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.23) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 8.71 M | ||||
| Shares Outstanding | 1.48 M | ||||
| Shares Owned By Insiders | 12.98 % | ||||
| Shares Owned By Institutions | 8.79 % | ||||
| Number Of Shares Shorted | 6.44 K | ||||
| Price To Earning | (1.14) X |
Pair Trading with Precipio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precipio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precipio will appreciate offsetting losses from the drop in the long position's value.Moving against Precipio Stock
| 0.76 | LH | Laboratory | PairCorr |
| 0.73 | GH | Guardant Health | PairCorr |
| 0.7 | VREX | Varex Imaging Corp | PairCorr |
| 0.68 | ENOV | Enovis Corp | PairCorr |
| 0.58 | DXCM | DexCom Inc | PairCorr |
The ability to find closely correlated positions to Precipio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precipio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precipio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precipio to buy it.
The correlation of Precipio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precipio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precipio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precipio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precipio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Precipio Stock, please use our How to Invest in Precipio guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precipio. If investors know Precipio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precipio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Revenue Per Share 11.73 | Quarterly Revenue Growth 0.257 | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Precipio is measured differently than its book value, which is the value of Precipio that is recorded on the company's balance sheet. Investors also form their own opinion of Precipio's value that differs from its market value or its book value, called intrinsic value, which is Precipio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precipio's market value can be influenced by many factors that don't directly affect Precipio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precipio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precipio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precipio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.